Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic

Due to the increasing prevalence of nonalcoholic steatohepatitis (NASH) and its associated health burden, there is a high need to develop therapeutic strategies for patients with this disease. Unfortunately, its long and asymptomatic natural history, the uncertainties about disease progression, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Filozof, Claudia, Chow, Shein‐Chung, Dimick‐Santos, Lara, Chen, Yeh‐Fong, Williams, Richard N., Goldstein, Barry J., Sanyal, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721443/
https://www.ncbi.nlm.nih.gov/pubmed/29404480
http://dx.doi.org/10.1002/hep4.1079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721443/
https://www.ncbi.nlm.nih.gov/pubmed/29404480
http://dx.doi.org/10.1002/hep4.1079

Ejemplares similares